Easymoneyman, the company I just bought is Aurinia Pharmaceutical, a small company with a product about to enter phase 3 for lupus nephritis, a serious unmet medical need. It is trading at about 2.40 with a small market cap. Phase 2B results will be announced in February which, if successful, should be a very big catalyst for the sp. The market for this lupus complication is very large and if this drug is approved we could easily be looking at a 10 bagger within the next couple of years...you might want to look into it.
News 
Market Data 
Discover 
